Clinical trial

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

NCT02331251

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Pembrolizumab Normalized identity: pembrolizumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Normalized identity: gemcitabineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Docetaxel Normalized identity: docetaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Nab-paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vinorelbine Normalized identity: vinorelbineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Irinotecan Normalized identity: irinotecanView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Liposomal Doxorubicin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2014-12-01

PhasePHASE1 / PHASE2

Conditions

Advanced Cancerunresolved

Breast Cancerverified · MONDO: breast cancer

Sarcomaverified · MONDO: sarcoma

Pancreatic Cancerverified · MONDO: malignant pancreatic neoplasm

Small Cell Lung Cancerverified · MONDO: small cell lung carcinoma

Ovarianunresolved

Interventions

PembrolizumabDRUG · verified · RxNorm: pembrolizumab

GemcitabineDRUG · verified · RxNorm: gemcitabine

DocetaxelDRUG · verified · RxNorm: docetaxel

Nab-paclitaxelDRUG

VinorelbineDRUG · verified · RxNorm: vinorelbine

IrinotecanDRUG · verified · RxNorm: irinotecan

Liposomal DoxorubicinDRUG

Sponsors & collaborators

Western Regional Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02331251 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.